CSX vs WHWK · P/E 19, rev $7.42B vs $202.8M cap
CSX Corporation (CSX) versus Whitehawk Therapeutics, Inc. (WHWK) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Latest reported CSX revenue for 2026-06-30 was $7.42B. Net income was $1.81B. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported WHWK revenue for 2026-06-30 was $0. Net income was -$38.8M. WHWK currently screens at market cap $202.8M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. WHWK currently screens at market cap $202.8M.
Not investment advice. Open the CSX and WHWK stock pages for the full models.
Not investment advice.